These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37132593)

  • 1. Transfection efficacy and drug release depends upon the PEG derivative in cationic lipoplexes: Evaluation in 3D in vitro model and in vivo.
    A M G; O O K; A S N; L I V; V A S; L A K; E A E; V V S; U A B; Yu L S; N E S; M R K; E M
    J Biomed Mater Res B Appl Biomater; 2023 Sep; 111(9):1614-1628. PubMed ID: 37132593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of PEG anchors in PEGylated siRNA lipoplexes on in vitro gene‑silencing effects and siRNA biodistribution in mice.
    Hattori Y; Tamaki K; Sakasai S; Ozaki KI; Onishi H
    Mol Med Rep; 2020 Nov; 22(5):4183-4196. PubMed ID: 33000194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lipopeptide structure on gene delivery system properties: Evaluation in 2D and 3D in vitro models.
    Koloskova OO; Gileva AM; Drozdova MG; Grechihina MV; Suzina NE; Budanova UA; Sebyakin YL; Kudlay DA; Shilovskiy IP; Sapozhnikov AM; Kovalenko EI; Markvicheva EA; Khaitov MR
    Colloids Surf B Biointerfaces; 2018 Jul; 167():328-336. PubMed ID: 29684902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness.
    Lechanteur A; Furst T; Evrard B; Delvenne P; Hubert P; Piel G
    Eur J Pharm Sci; 2016 Oct; 93():493-503. PubMed ID: 27593989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity.
    Belletti D; Tosi G; Forni F; Lagreca I; Barozzi P; Pederzoli F; Vandelli MA; Riva G; Luppi M; Ruozi B
    Eur J Pharm Biopharm; 2016 Feb; 99():7-17. PubMed ID: 26625717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated galactosylated cationic liposomes for hepatocytic gene delivery.
    Naicker K; Ariatti M; Singh M
    Colloids Surf B Biointerfaces; 2014 Oct; 122():482-490. PubMed ID: 25096720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection.
    Gjetting T; Arildsen NS; Christensen CL; Poulsen TT; Roth JA; Handlos VN; Poulsen HS
    Int J Nanomedicine; 2010 Aug; 5():371-83. PubMed ID: 20957159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenon.
    Li Y; Liu R; Shi Y; Zhang Z; Zhang X
    Theranostics; 2015; 5(6):583-96. PubMed ID: 25825598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of PEG anchor in PEGylation of folate-modified cationic liposomes with PEG-derivatives on systemic siRNA delivery into the Tumor.
    Tang M; Sakasai S; Onishi H; Kawano K; Hattori Y
    J Drug Target; 2023 Jan; 31(1):74-88. PubMed ID: 35864749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells.
    Peeters L; Sanders NN; Jones A; Demeester J; De Smedt SC
    J Control Release; 2007 Aug; 121(3):208-17. PubMed ID: 17630013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of cell penetration enhancer shielding and endosomal escape-kinetics crucial for efficient and biocompatible siRNA delivery.
    Malfanti A; Sami H; Balasso A; Marostica G; Arpac B; Mastrotto F; Mantovani G; Cola E; Anton M; Caliceti P; Ogris M; Salmaso S
    J Control Release; 2023 Nov; 363():101-113. PubMed ID: 37722420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgene expression in mice of the Opa1 mitochondrial transmembrane protein through bicontinuous cubic lipoplexes containing gemini imidazolium surfactants.
    Muñoz-Úbeda M; Semenzato M; Franco-Romero A; Junquera E; Aicart E; Scorrano L; López-Montero I
    J Nanobiotechnology; 2021 Dec; 19(1):425. PubMed ID: 34922554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells.
    Oliveira AC; Raemdonck K; Martens T; Rombouts K; Simón-Vázquez R; Botelho C; Lopes I; Lúcio M; González-Fernández Á; Real Oliveira ME; Gomes AC; Braeckmans K
    Acta Biomater; 2015 Oct; 25():216-29. PubMed ID: 26225736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
    Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydration of surfactant-modified and PEGylated cationic cholesterol-based liposomes and corresponding lipoplexes by monitoring a fluorescent probe and the dielectric relaxation time.
    Maitani Y; Nakamura A; Tanaka T; Aso Y
    Int J Pharm; 2012 May; 427(2):372-8. PubMed ID: 22348874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy.
    Haghiralsadat F; Amoabediny G; Naderinezhad S; Forouzanfar T; Helder MN; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):684-692. PubMed ID: 29475393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Cationic Lipid Type in Folate-PEG-Modified Cationic Liposomes on Folate Receptor-Mediated siRNA Transfection in Tumor Cells.
    Hattori Y; Shimizu S; Ozaki KI; Onishi H
    Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30991703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sterol derivatives in cationic liposomes on biodistribution and gene-knockdown in the lungs of mice systemically injected with siRNA lipoplexes.
    Hattori Y; Saito H; Oku T; Ozaki KI
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.